Close
Nordic 9Nordic 9

Nexus NeuroTech Ventures (investor - Venture Capital)

United States nexusneurotech.com
See something wrong or missing? Let us know
Offices:San Francisco

Nexus NeuroTech Ventures is an American investment company founded in 2023 and doing deals with startups helping people with neurodegenerative,  neuropsychiatric, and neurodevelopmental disorders, such as Parkinson’s disease, bipolar disorder, and autism spectrum disorder.

Average round investment:36.23M USD
Average number per year:1.0
Distribution: 2025 (1)
Portfolio companies: Belgium Nobi
Mostly invests in: Belgium Belgium (1) Hardware (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Nexus NeuroTech Ventures

Name Criteria
Japan 15th Rock
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Hardware, Health services, Manufacturing, Mobile, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Belgium
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium Balz Halter
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Hardware, Health services, Manufacturing, Mobile, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Belgium
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium UCB Ventures
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Belgium
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United Kingdom Isomer Capital
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Belgium
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
United States New Science Ventures
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Belgium
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Switzerland MTIP AG
90%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Mobile, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Belgium
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Belgium BNP Paribas Fortis Private Equity
90%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Hardware, Health services, Manufacturing, Mobile, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Belgium
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Belgium Gimv
90%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Hardware, Health services, Manufacturing, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Belgium
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Netherlands BioGeneration Ventures
89%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Belgium
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
United States CourtsideVC
89%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Mobile, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Belgium
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Top